Table 1.

Participant Characteristics.

Characteristic	N=13
Persons with CF	8
Age 12−17 years	2
Age >18 years	6
CFTR modulator use	6
Advanced CF lung disease (FEV1 <40% predicted)	3
Lung transplant recipient	1
Caregivers of persons with CF	5
Parent of child ages 0-11 years	2
Parent of adolescent ages 12-17 years	1
Parent of adult	1
Partner/spouse	1
Caregiver of patient with advanced lung disease	1
Caregiver of patient using CFTR modulator therapy	2
Participant sex
Male	6
Female	7
Participant Race/Ethnicity
Non-Hispanic White	8
Non-Hispanic Black	2
Hispanic	2
Asian	1